The FDA has delayed its target decision date for Orca Bio’s blood cancer cell therapy candidate Orca-T by three months to ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the 5 Best Stocks to Buy for Short Term. On March 25, Wolfe Research ...
6h
A Look At Turning Point Brands (TPB) Valuation As FDA Nicotine Pouch Delays Raise Growth Questions
Turning Point Brands (TPB) has been hit by a wave of regulatory headlines, as reports of the Food and Drug Administration slowing nicotine pouch approvals triggered a sharp selloff and raised fresh ...
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...
At the highest levels of the FDA, questions remain about which officials have the legal authority to sign off on drugs cleared under the Commissioner’s National Priority Voucher program, which ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results